IndraLab

Statements


| 2

reach
"Conclusion: USP14 can promote the malignant progression and ibrutinib sensitivity of MCL by stabilizing XPO1."

reach
"USP14 promotes the malignant progression and ibrutinib resistance of mantle cell lymphoma by stabilizing XPO1."